Symmetry Investments LP Purchases Shares of 6,100 Crocs, Inc. (NASDAQ:CROX)

Symmetry Investments LP purchased a new stake in Crocs, Inc. (NASDAQ:CROX) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,100 shares of the textile maker’s stock, valued at approximately $890,000.

A number of other hedge funds have also recently bought and sold shares of CROX. Coatue Management LLC boosted its holdings in Crocs by 836.7% in the 4th quarter. Coatue Management LLC now owns 1,029,765 shares of the textile maker’s stock valued at $96,190,000 after purchasing an additional 919,835 shares during the period. Norges Bank bought a new position in shares of Crocs during the 4th quarter worth about $72,211,000. Patient Capital Management LLC bought a new position in shares of Crocs during the 4th quarter worth about $39,420,000. Goldman Sachs Group Inc. lifted its holdings in shares of Crocs by 46.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 770,281 shares of the textile maker’s stock worth $71,952,000 after acquiring an additional 245,240 shares during the period. Finally, National Bank of Canada FI lifted its holdings in shares of Crocs by 8,437.1% during the 2nd quarter. National Bank of Canada FI now owns 182,695 shares of the textile maker’s stock worth $26,993,000 after acquiring an additional 180,555 shares during the period. 93.44% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. UBS Group reduced their price objective on shares of Crocs from $148.00 to $146.00 and set a “neutral” rating for the company in a report on Tuesday, July 16th. Williams Trading raised shares of Crocs from a “hold” rating to a “buy” rating and raised their price objective for the stock from $135.00 to $163.00 in a report on Thursday, August 22nd. Barclays dropped their target price on shares of Crocs from $169.00 to $164.00 and set an “overweight” rating for the company in a research report on Friday, August 2nd. Bank of America increased their target price on shares of Crocs from $160.00 to $187.00 and gave the stock a “buy” rating in a research report on Thursday, June 20th. Finally, Wedbush reiterated an “outperform” rating and set a $170.00 target price on shares of Crocs in a research report on Monday, July 29th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Crocs presently has a consensus rating of “Moderate Buy” and an average target price of $160.27.

Crocs Trading Up 0.8 %

CROX opened at $139.05 on Friday. The company has a current ratio of 1.50, a quick ratio of 0.95 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $8.44 billion, a PE ratio of 10.76, a PEG ratio of 1.29 and a beta of 2.00. Crocs, Inc. has a 1-year low of $74.00 and a 1-year high of $165.32. The firm has a 50-day moving average price of $134.34 and a two-hundred day moving average price of $137.70.

Crocs (NASDAQ:CROX) last posted its quarterly earnings data on Thursday, August 1st. The textile maker reported $4.01 earnings per share for the quarter, beating the consensus estimate of $3.59 by $0.42. The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.10 billion. Crocs had a net margin of 20.02% and a return on equity of 53.20%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the company posted $3.59 EPS. As a group, equities analysts anticipate that Crocs, Inc. will post 12.85 earnings per share for the current fiscal year.

Insider Buying and Selling at Crocs

In other news, Director Douglas J. Treff sold 10,594 shares of Crocs stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the completion of the sale, the director now owns 81,254 shares in the company, valued at approximately $10,756,404.52. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Crocs news, Director John B. Replogle purchased 1,996 shares of the stock in a transaction dated Friday, August 2nd. The stock was bought at an average price of $123.96 per share, for a total transaction of $247,424.16. Following the transaction, the director now directly owns 7,064 shares in the company, valued at $875,653.44. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Douglas J. Treff sold 10,594 shares of Crocs stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the transaction, the director now directly owns 81,254 shares in the company, valued at approximately $10,756,404.52. The disclosure for this sale can be found here. Corporate insiders own 2.72% of the company’s stock.

About Crocs

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.